Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

Apr 28, 2021

SELL
$102.3 - $112.62 $1.54 Million - $1.69 Million
-15,050 Closed
0 $0
Q4 2020

Feb 03, 2021

BUY
$80.49 - $108.67 $1.21 Million - $1.64 Million
15,050 New
15,050 $1.61 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Hunter Perkins Capital Management, LLC Portfolio

Follow Hunter Perkins Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hunter Perkins Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hunter Perkins Capital Management, LLC with notifications on news.